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An 84-year-old man presented with recent-onset 
odynophagia and a two-year history of dyspepsia and 
heartburn. Oesophagogastroduodenoscopy (OGD) disclosed 
longitudinal sheets of sloughed squamous tissue with normal 
underlying mucosa involving the mid oesophagus and 
consistent with oesophagitis dissecans superficialis (ODS) 
(Fig. 1). Histopathology showed detached epithelial fragments 
lacking a basal layer with a nonspecific inflammatory infiltrate. 
Direct immunofluorescence (DIF) of perilesional mucosa 
revealed linear IgG deposits along the basement membrane 
zone (BMZ) (Fig. 2). Indirect immunofluorescence and 
enzyme-linked immunoassay for anti-BP 180, anti-BP 230 and 
anti-desmoglein antibodies were negative. Oesophagus-limited 
mucous membrane pemphigoid (MMP) was diagnosed. Pulsed 
intravenous methylprednisolone (125 mg/day for five days) 
followed by steroid tapering was given in combination with 
pantoprazole 40 mg/day, without any improvement. Thereafter, 
oral cyclophosphamide 100 mg/day was added. Over the next 
two months, symptoms gradually subsided concomitant with 
a normalization of the endoscopic picture (Fig. 3). Clinical 
remission persisted at the 37-months follow-up visit. 
Oesophagitis dissecans superficialis is an exfoliative 
oesophageal disorder which may be associated with physical and 
chemical traumas, drugs, collagen diseases and autoimmune 
blistering diseases [1], notably pemphigus vulgaris and, more 
rarely, MMP, a mucous membrane-dominated subepithelial 
bullous disease caused by antibodies to different autoantigens 
of the BMZ [2]. Cases of classic MMP with oral, ocular and/
or genital lesions manifesting also as ODS have been rarely 
reported [3, 4], possibly due to the underestimation of 
oesophageal symptoms by dermatologists and the inexperience 
with such lesions for most endoscopists. Furthermore, 
considering that oesophageal MMP usually occurs in the 
context of classic MMP with oral involvement and is typical in 
late stages [5], the exclusive oesophageal involvement at disease 
onset makes our case even more exceptional. 
This case highlights that DIF should be performed when an 
endoscopic picture of ODS raises the suspicion of MMP, even 
in the absence of other skin and/or mucosal lesions. 
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